Modification of primary and recurrent genital herpes in guinea pigs by passive immunization

References

1. Bernstein D. I., Harrison C. J. 1989; Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections. Antimicrobial Agents and Chemotherapy 33:1511–1515
   [Google Scholar]
2. Bernstein D. I., Stanberry L. R., Harrison C. J., Kappes J., Myers M. G. 1986; Antibody response, recurrence pattern and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea pigs: effects of acyclovir. Journal of General Virology 67:1601–1612
   [Google Scholar]
3. Bourne N., Stanberry L. R., Bernstein D. I., Lew D. 1996; DNA immunization against experimental genital herpes simplex virus infection. Journal of Infectious Diseases 173:800–807
   [Google Scholar]
4. Kavaliotis J., Loukou I., Trachana M., Gombakis N., Tsargaropoulou-Stigga H., Koliouskas D. 1998; Outbreak of varicella in a pediatric oncology unit. Medical and Pediatric Oncology 31:166–169
   [Google Scholar]
5. Klein R. J. 1980; Effect of immune serum on the establishment of herpes simplex virus infection in trigeminal ganglia of hairless mice. Journal of General Virology 49:401–405
   [Google Scholar]
6. McKendall R. R., Klassen T., Baringer J. R. 1979; Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread. Infection and Immunity 23:305–311
   [Google Scholar]
7. Morrison L. A., Zhu L., Thebeau L. G. 2001; Vaccine-induced serum immunoglobulin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells. Journal of Virology 75:1195–1204
   [Google Scholar]
8. Oakes J. E., Rosemund-Hornbeak H. 1978; Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection. Infection and Immunity 21:489–495
   [Google Scholar]
9. Sawyer L. A. 2000; Antibodies for the prevention and treatment of viral diseases. Antiviral Research 47:57–77
   [Google Scholar]
10. Shimeld C. T., Hill J., Blyth W. A., Easty D. L. 1990; Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system. Journal of General Virology 71:681–687
    [Google Scholar]
11. Snydman D. R. 1990; Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease. Reviews of Infectious Diseases 12 (Suppl. 7):839–847
    [Google Scholar]
12. Stanberry L. R., Kern E. R., Richards J. T., Abbott T. M., Overall Overall. J. Jr 1982; Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. Journal of Infectious Diseases 146:397–401
    [Google Scholar]
13. Stanberry L. R., Kern E. R., Richards J. T., Overall Overall. J. Jr 1985; Recurrent genital herpes simplex virus infection in guinea pigs. Intervirology 24:226–231
    [Google Scholar]
14. Stanberry L. R., Bernstein D. I., Burke R. L., Pachl C., Myers M. G. 1987; Recombinant herpes simplex virus glycoprotein vaccine protects against initial and recurrent genital herpes. Journal of Infectious Diseases 155:397–404
    [Google Scholar]
15. Wachsman M., Kulka M., Smith C. C., Aurelian L. 2001; A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigs. Vaccine 19:1879–1890
    [Google Scholar]
16. Walz M. A., Yamamoto H., Notkins A. L. 1976; Immunologic response restricts number of cells in sensory ganglia infected with herpes simplex virus. Nature 264:554–556
    [Google Scholar]
17. Zaia J. A., Levin M. J., Preblud S. R., Leszczynski J., Wright G. G., Ellis R. J., Curtis A. C., Valerio M. A., LeGore J. 1983; Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. Journal of Infectious Diseases 147:737–743
    [Google Scholar]